カリフォルニア州における食道癌の臨床試験
カリフォルニア州内の拠点で、食道癌に関する41件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles15件の研究
- Baldwin Park14件の研究
- San Diego10件の研究
- Santa Monica7件の研究
- Mountain View7件の研究
- Orange6件の研究
- Irvine5件の研究
- Concord4件の研究
- San Francisco4件の研究
- Sacramento4件の研究
- Fullerton3件の研究
- Stockton3件の研究
- Santa Rosa3件の研究
公式研究テキスト(英語)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/10/05更新 · NCT06995898A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- City of Hope National Medical Center, Duarte
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- UCLA Hematology/Oncology - Santa Monica ( Site 4905), Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05319730A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- 他8件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- 他10件
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- 他20件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- Ronald Reagan UCLA Medical Center, Los Angeles
- 他3件
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07090499Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Precision NextGen Oncology, Beverly Hills
- OPN Healthcare, Inc, Glendale
- University of Southern California, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Pan-tumor MRD Study
- Los Angeles Cancer Network (LACN), Glendale
- Ventura County Hematology Oncology Specialists, Oxnard
- Medical Oncology Associates of San Diego (MOASD), San Diego
- 他2件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06605404A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- City of Hope, Duarte
- University of California, Los Angeles (UCLA), Santa Monica
- Stanford University Medical Center, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213791Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Beverly Hills Cancer Center, Beverly Hills
- City of Hope Cancer Center, Duarte
- University of California Irvine Medical Center, Orange
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
- Helios CR Inc./RadNet, Cerritos
- City of Hope National Cancer Center, Duarte
- Hoag Memorial Hospital, Irvine
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07217704ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of California, San Diego, La Jolla
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Redwood City, Redwood City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- City of Hope, Duarte
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
- Research Site, Duarte
- Research Site, Fountain Valley
- Research Site, Fullerton
- 他5件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07431281Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
- UCLA Hematology/Oncology - Santa Monica ( Site 8905), Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06445972Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
- UCLA Hematology/Oncology - Santa Monica ( Site 6905), Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06469944Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/31更新 · NCT07795749Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
- UCLA, Santa Monica
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07070466A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- UC San Diego Moores Cancer Center, San Diego
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT07227168Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- University of California, San Francisco, San Francisco
- John Muir Medical Center-Walnut Creek, Walnut Creek
被験者募集中
18歳以上 · 全性別 · 2026/08/14更新 · NCT04221893A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
- UCSD, La Jolla
- Sharp Healthcare, San Diego
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/29更新 · NCT03526835A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Providence Medical Foundation, Anaheim
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center Virginia K Crosson and Infusion Center, Fullerton
- 他7件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- City of Hope National Medical Center /ID# 276272, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589, Irvine
- USC Norris Comprehensive Cancer Center /ID# 279603, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT05005403Proton Therapy for Esophageal Cancer
- Loma Linda University Medical Center, Loma Linda
被験者募集中
18歳以上 · 全性別 · 2026/06/05更新 · NCT01684904Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Beckman Research Institute of City of Hope, Duarte
- VA Medical Center, Fresno, Fresno
- Santa Clara Valley Medical Center, Fruitdale
- 他5件
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中
18歳〜99歳 · 全性別 · 2026/02/20更新 · NCT04907643cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- Stanford University School of Medicine, Stanford
被験者募集中観察研究
18歳以上 · 全性別 · 2025/12/18更新 · NCT01048281A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- University of Southern California, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/12/11更新 · NCT06943521VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Providence Medical Foundation (site 209), Santa Rosa
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- 他3件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
- Cedars-Sinai Medical Center, Los Angeles
被験者募集中第4相
18歳以上 · 全性別 · 2025/09/15更新 · NCT0712435164Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- City of Hope, Duarte
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
- Stanford Hospital & Clinics, Stanford
被験者募集中第1/2相
15歳以上 · 全性別 · 2025/08/12更新 · NCT06298916A Beta-only IL-2 ImmunoTherapY Study
- Sharp Memorial Hospital, San Diego
- Providence Saint John's Health Center, Santa Monica
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/07/09更新 · NCT05086692ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。